본문 바로가기

Data Plus(+)

All 807,818 Page 4,362/80,782

검색

Contents

No Journal_name Subject Date DOI Author
764208 JOURNAL FOR IMMUNOTHERAPY OF CANCER 409 Trial in progress: a phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancer 2021-11-01 10.1136/jitc-2021-sitc2021.409 Oh Do-Youn, Ryu Min Hee, Hwang Jun-Eul, Cho Jaeyong, Zang Dae Young, Oh Sang Cheul, Lee Jeeyun, Lee Keun-Wook, Chung Hyun Cheol, Shim Byoung Yong, Chisamore Michael, Ho William, Rhee Paul, Won Ji Yeong, Kim Taewan, Baek Eunhye, Baek SeungJae
764207 JOURNAL FOR IMMUNOTHERAPY OF CANCER 685 Characterization of molecular and spatial diversity of macrophages in hepatocellular carcinoma 2021-11-01 10.1136/jitc-2021-sitc2021.685 Hamon Pauline, Magen Assaf, Kim Joel, Buckup Mark, Troncoso Leanna, Hamel Steven, Berichel Jessica Le, Barboy Oren, David Eyal, Tabachnikova Alexandra, Chang Christie, Zhao Zhen, Cohen Merav, Giladi Amir, Malissen Nausicaa, Desland Fiona, Amit Ido, Kenigsberg Ephraim, Schwartz Myron, Marron Thomas, Merad Miriam
764206 JOURNAL FOR IMMUNOTHERAPY OF CANCER 306 Decr2 regulates tumor cell ferroptosis and is required for immunotherapy efficacy 2021-11-01 10.1136/jitc-2021-sitc2021.306 Li Shuyin, Gajewski Thomas, Li Shuyin, Higgs Emily
764205 JOURNAL FOR IMMUNOTHERAPY OF CANCER 713 Novel protease activatable linker with tumor targeting motifs enhances the retention of cytokine prodrug and active cytokine at disease site and demonstrates improved efficacy in preclinical model 2021-11-01 10.1136/jitc-2021-sitc2021.713 Langley Emma, Li Chen, Zaid Jessica, Lee Tani-Ann, Yadav Deepak, Grot Brian, Singh Jay, Kim Johnovan
764204 JOURNAL FOR IMMUNOTHERAPY OF CANCER 712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties 2021-11-01 10.1136/jitc-2021-sitc2021.712 Jaekel Anika, Kehler Patrik, Lischke Timo, Goletz Christoph, Flechner Anke, Danielczyk Antje, Gellert Johanna
764203 JOURNAL FOR IMMUNOTHERAPY OF CANCER 711 IGM-7354 is an anti-PD-L1 IgM antibody and IL-15 cytokine fusion that enhances NK and CD8+ T cell proliferation and tumor cytotoxicity plus potently reverses T cell exhaustion 2021-11-01 10.1136/jitc-2021-sitc2021.711 Giffon Thierry, Desbois Melanie, Ng Dean, Yakkundi Poonam, Manlusoc Marigold, Oyasu Miho, Rosete Rodnie, Machado Daniel, Calhoun Susan, Kothambawala Tasnim, Saini Avneesh, Wang Beatrice, Kotturi Maya, Keyt Bruce, Sinclair Angus
764202 JOURNAL FOR IMMUNOTHERAPY OF CANCER 710 Differences in the susceptibility of human small cell lung cancer variants to NK cell-mediated lysis can be overcome with the addition of N803 (IL-15 superagonist) 2021-11-01 10.1136/jitc-2021-sitc2021.710 Fousek Kristen, Horn Lucas, Qin Haiyan, Reddy Bobby, Sender Lennie, Shiong Patrick Soon, Schlom Jeffrey, Palena Claudia
764201 JOURNAL FOR IMMUNOTHERAPY OF CANCER 709 Peptidyl IL-2/15Rβγc-restricted agonists, highly-attenuated and linked to anti-PD-1 antibodies to achieve selectivity and amplified potency in stimulating PD-1high lymphocytes 2021-11-01 10.1136/jitc-2021-sitc2021.709 Dower William, Bakker Alice, Cwirla Steven, Williams Blake, Joshi Prarthana, Pongtornpipat Praechompoo, Needels Michael, Barrett Ronald
764200 JOURNAL FOR IMMUNOTHERAPY OF CANCER 708 Novel ways to exploit IL-21 to augment adoptive T cell transfer therapy against tumors 2021-11-01 10.1136/jitc-2021-sitc2021.708 Cole Anna, RIvera Guillermo Rangel, Smith Aubrey, Wyatt Megan, Ware Brandon, Knochelmann Hannah, Paulos Chrystal
764199 JOURNAL FOR IMMUNOTHERAPY OF CANCER 707 IL12 Fc-fusions engineered for reduced potency and extended half-life exhibit strong anti-tumor activity and improved therapeutic index compared to wild-type IL12 agents 2021-11-01 10.1136/jitc-2021-sitc2021.707 Bernett Matthew, Liu Ke, Bonzon Christine, Hackett Michael, Bykova Katrina, Rashid Rumana, Rodriguez Nicole, Hassanzadeh-Kiabi Nargess, Ardila Connie, Barlow Norman, Leung Irene, Nguyen Hanh, Eivazi Araz, Avery Kendra, Varma Rajat, Muchhal Umesh, Desjarlais John